Classes
Publications
- Predicting effects of immunotherapy2018 | First Faculty of Medicine
- The Inclusion of a Gemcitabine + Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience2017 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Molecular Oncology in Case Reports2017 | First Faculty of Medicine, Third Faculty of Medicine
- The Inclusion of a Gemcitabine + Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience2017 | First Faculty of Medicine
- Imunoterapie nádorových onemocnění z pohledu imunologa2016 | First Faculty of Medicine
- Cancer Immunology2015 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Regorafenib jako součást léčebného algoritmu metastazujícího kolorektálního karcinomu2015 | First Faculty of Medicine
- New perspectives on pharmacotherapy in the algorithm of colorectal cancer liver metastases management2014 | First Faculty of Medicine
- Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial2023 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Science, Faculty of Mathematics and Physics
- Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial2023 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University, Faculty of Science, Faculty of Mathematics and Physics
Loading network view...